Academic Journal

Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor Prognosis

التفاصيل البيبلوغرافية
العنوان: Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor Prognosis
المؤلفون: Bahri, Rajia, Kiss, Orsolya, Prise, Ian, Garcia-Rodriguez, Karen M, Atmoko, Haris, Martínez-Gómez, Julia M, Levesque, Mitchell Paul, Dummer, Reinhard, Smith, Michael P, Wellbrock, Claudia, Bulfone-Paus, Silvia
المصدر: Bahri, Rajia; Kiss, Orsolya; Prise, Ian; Garcia-Rodriguez, Karen M; Atmoko, Haris; Martínez-Gómez, Julia M; Levesque, Mitchell Paul; Dummer, Reinhard; Smith, Michael P; Wellbrock, Claudia; Bulfone-Paus, Silvia (2022). Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor Prognosis. Frontiers in Immunology, 13:861545.
بيانات النشر: Frontiers Research Foundation
سنة النشر: 2022
المجموعة: University of Zurich (UZH): ZORA (Zurich Open Repository and Archive
مصطلحات موضوعية: Dermatology Clinic, 610 Medicine & health, Immunology, Immunology and Allergy
الوصف: Cutaneous melanoma is one of the most aggressive human malignancies and shows increasing incidence. Mast cells (MCs), long-lived tissue-resident cells that are particularly abundant in human skin where they regulate both innate and adaptive immunity, are associated with melanoma stroma (MAMCs). Thus, MAMCs could impact melanoma development, progression, and metastasis by secreting proteases, pro-angiogenic factors, and both pro-inflammatory and immuno-inhibitory mediators. To interrogate the as-yet poorly characterized role of human MAMCs, we have purified MCs from melanoma skin biopsies and performed RNA-seq analysis. Here, we demonstrate that MAMCs display a unique transcriptome signature defined by the downregulation of the FcεRI signaling pathway, a distinct expression pattern of proteases and pro-angiogenic factors, and a profound upregulation of complement component C3. Furthermore, in melanoma tissue, we observe a significantly increased number of C3$^{+}$ MCs in stage IV melanoma. Moreover, in patients, C3 expression significantly correlates with the MC-specific marker TPSAB1, and the high expression of both markers is linked with poorer melanoma survival. In vitro, we show that melanoma cell supernatants and tumor microenvironment (TME) mediators such as TGF-β, IL-33, and IL-1β induce some of the changes found in MAMCs and significantly modulate C3 expression and activity in MCs. Taken together, these data suggest that melanoma-secreted cytokines such as TGF-β and IL-1β contribute to the melanoma microenvironment by upregulating C3 expression in MAMCs, thus inducing an MC phenotype switch that negatively impacts melanoma prognosis.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
تدمد: 1664-3224
Relation: https://www.zora.uzh.ch/id/eprint/220002/1/ZORA_pdf.pdf; info:pmid/35669782; urn:issn:1664-3224
DOI: 10.3389/fimmu.2022.861545
الاتاحة: https://www.zora.uzh.ch/id/eprint/220002/
https://www.zora.uzh.ch/id/eprint/220002/1/ZORA_pdf.pdf
https://doi.org/10.3389/fimmu.2022.861545
Rights: info:eu-repo/semantics/openAccess ; Creative Commons: Attribution 4.0 International (CC BY 4.0) ; http://creativecommons.org/licenses/by/4.0/
رقم الانضمام: edsbas.E883F4F6
قاعدة البيانات: BASE
الوصف
تدمد:16643224
DOI:10.3389/fimmu.2022.861545